Clinical Trial Update: Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial results assessing the efficacy and safety of inhaled insulin in adults with Type 1 diabetes have been completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Diabetes, Type I | Phase 3 | Status: COMPLETED | Results posted: 2014-10-16